GRM5 and Alzheimer disease: Considering the protein expression level of mGluR5 fluctuated with the progression of AD in 5xFAD mice mode [35], longitudinal PET imaging of [18F]PSS232 on AD patients and healthy volunteers is warranted to investigate whether the alteration of mGluR5 receptors could predict the clinical progression of AD.